4

OWNERSHIP DOCUMENT

Company: BioXcel Therapeutics, Inc.
Filed: July 31, 2025
Period of Report: July 31, 2025
Accession Number: 0001104659-25-072701

View Document ↗ View on SEC.gov ↗